Curbing an inhibitor for hemostasis.
Antibodies against factor VIII cause severe bleeding, requiring therapy that circumvents the normal coagulation pathway. In this issue of Blood, Waters and colleagues report that a novel RNA polymer can block an inhibitor of tissue factor,unleashing native procoagulant activity that stops the bleeding.